Evidence map›Paper›PMID 36803833›Full record

ArticleHarm reduction journal2023

Legal sourcing of ten cannabis products in the Canadian cannabis market, 2019-2021: a repeat cross-sectional study.

Elle Wadsworth, Vicki Rynard, Pete Driezen, Tom P Freeman, Marta Rychert, Chris Wilkins, Wayne Hall, Robert Gabrys, David Hammond

Abstract read
In one paragraph

Article in Harm reduction journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Impact of legalization on cannabis exposure calls to the British Columbia Poison Control Centre.Canadian journal of public health = Revue canadienne de sante publique · 2026
    Article
  3. Article
  4. Article
  5. Should cannabis self-cultivation be part of a public health‒oriented legalization policy framework?Canadian journal of public health = Revue canadienne de sante publique · 2024
    Article
  6. Article
  7. Article
  8. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2023
    Article
  9. Outcomes associated with nonmedical cannabis legalization policy in Canada: taking stock at the 5-year mark.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2023
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Elle WadsworthSchool of Public Health Sciences, University of Waterloo, 200 University Ave W, Waterloo, ON, N2L 3G1, Canada. ewadsworth@uwaterloo.ca.
Vicki RynardSchool of Public Health Sciences, University of Waterloo, 200 University Ave W, Waterloo, ON, N2L 3G1, Canada.
Pete DriezenSchool of Public Health Sciences, University of Waterloo, 200 University Ave W, Waterloo, ON, N2L 3G1, Canada.
Tom P FreemanAddiction and Mental Health Group (AIM), Department of Psychology, University of Bath, Bath, BA2 7AY, UK.
Marta RychertSHORE & Whāriki Research Centre, College of Health, Massey University, Palmerston North, New Zealand.
Chris WilkinsSHORE & Whāriki Research Centre, College of Health, Massey University, Palmerston North, New Zealand.
Wayne HallNational Centre for Youth Substance Use Research, The University of Queensland, St Lucia, Australia.
Robert GabrysCanadian Centre on Substance Use and Addiction, 75 Albert St, Suite 500, Ottawa, ON, K1P 5E7, Canada.
David HammondSchool of Public Health Sciences, University of Waterloo, 200 University Ave W, Waterloo, ON, N2L 3G1, Canada.

Funding

CIHR PJT-153342
6 · The paper itself

Abstract

backgroundOne of the objectives of cannabis legalization in Canada is to transition consumers from the illegal to the legal market. Little is known about how legal sourcing varies across different cannabis product types, provinces, and frequency of cannabis use.

methodsData were analyzed from Canadian respondents in the International Cannabis Policy Study, a repeat cross-sectional survey conducted annually from 2019 to 2021. Respondents were 15,311 past 12-month cannabis consumers of legal age to purchase cannabis. Weighted logistic regression models estimated the association between legal sourcing ("all"/ "some"/ "none") of ten cannabis product types, province, and frequency of cannabis use over time.

resultsThe percentage of consumers who sourced "all" their cannabis products from legal sources in the past 12 months varied by product type, ranging from 49% of solid concentrate consumers to 82% of cannabis drink consumers in 2021. The percentage of consumers sourcing "all" their respective products legally was greater in 2021 than 2020 across all products. Legal sourcing varied by frequency of use: weekly or more frequent consumers were more likely to source "some" (versus "none") of their products legally versus less frequent consumers. Legal sourcing also varied by province, with a lower likelihood of legal sourcing in Québec of products whose legal sale was restricted (e.g., edibles).

conclusionLegal sourcing increased over time, demonstrating progress in the transition to the legal market for all products in the first three years of legalization in Canada. Legal sourcing was highest for drinks and oils and lowest for solid concentrates and hash.

Indexed as

CannabisMarijuana UseCanadaCross-Sectional StudiesHumansLegislation, DrugCannabisLegalizationLegal marketsMarijuanaSourcing

Identifiers

PMID36803833
PMCPMC9936931

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.